In 2001, researchers isolated GSDMC (also known as MLZE) for the first time from mouse melanoma cells and observed that as the metastatic ability of the tumor increased, the expression of GSDMC rose accordingly,17 a finding that provided insights into the genetic variation underlying the progression of melanoma. This evidence concerns the gene GSDMC and melanoma.